FB301 for women with vaginal imbalance and prior failed embryo transfer
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests whether a vaginal gel (FB301) can improve the balance of bacteria in the vagina for women who have had a failed frozen embryo transfer. If you are planning another frozen embryo transfer and have a specific vaginal bacteria imbalance, this trial may help you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 40 with regular periods.
- You have had at least one prior frozen embryo transfer that failed (not due to male infertility or blocked tubes).
- You are planning another frozen embryo transfer using one good-quality embryo.
- A vaginal swab shows an imbalance in your vaginal bacteria (as needed for this study).
- Blood tests and ultrasound show you are healthy enough for the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting “good bacteria” into the vagina can treat recurrent bacterial vaginosis (BV). It may help restore a healthier vaginal bacterial balance and reduce BV episodes.
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
This study tests whether introducing beneficial organisms into the vagina can help treat bacterial vaginosis (a common vaginal imbalance). You'll be part of the FRESH research program and receive either the treatment or a comparison option.
This study looks at how bacteria in the vagina and lining of the uterus change during the “luteal phase” (the time after ovulation and before a pregnancy test) in people using frozen embryo transfers. It may help researchers understand what conditions support embryo implantation and pregnancy in assisted reproduction.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This study tests whether a probiotic (a pill with beneficial bacteria) can help improve the health of the female genital tract for people with fertility problems who are undergoing IVF. It aims to see if this can improve chances of pregnancy.
Hear when a new Vaginal Dysbiosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.